Aleks Engel speaking at World Antimicrobial Resistance Congress

Aleks Engel, Director,
REPAIR Impact Fund, Novo Holdings

 

What do you see as the biggest challenges facing the AMR space into 2022? 

  • Loss of further talent to other therapeutic areas due to lack of funding 
  • Further bankruptcies that will further scare away investors 

 

If you could wave a magic wand, what would you like to see occur in the coming year to further combat AMR? 

  • The passage of the PASTEUR Act.  We absolute need it 
 
What would you like to highlight about your work/your organization for this coming year? 
  • We are working on closing two new investments in Q1 
  • We will open the REPAIR Impact Fund 2022 call for proposals in May 
 
Do you have any predictions for the AMR space in 2022 and beyond? Any calls-to-action you’d like to highlight? 
  • The G7 finance ministers will realize that without reimbursement reform their countries will not get access to new drugs will finally move on subscription models 
 
 
 

 


GET INVOLVED AT THE

WORLD ANTI-MICROBIAL RESISTANCE CONGRESS

 

To Sponsor Or Exhibit

 


Semen Sen

semen.sen@terrapinn.com
+1 646.619.1793

 

 

To Speak

 


Emma Goaley

emma.goaley@terrapinn.com
+1 646.400.2576

 

 

Press & Media Partnerships

 


Ipek Coskun

ipek.coskun@terrapinn.com
+1 407.421.5818